FR31M - New drug in particular for the treatment of arterial hypertension. - Google Patents

New drug in particular for the treatment of arterial hypertension.

Info

Publication number
FR31M
FR31M FR832803A FR832803A FR31M FR 31 M FR31 M FR 31M FR 832803 A FR832803 A FR 832803A FR 832803 A FR832803 A FR 832803A FR 31 M FR31 M FR 31M
Authority
FR
France
Prior art keywords
treatment
new drug
arterial hypertension
arterial
hypertension
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR832803A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Francais de Chimiotherapie SA
Original Assignee
Laboratoires Francais de Chimiotherapie SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Francais de Chimiotherapie SA filed Critical Laboratoires Francais de Chimiotherapie SA
Application granted granted Critical
Publication of FR31M publication Critical patent/FR31M/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D459/00Heterocyclic compounds containing benz [g] indolo [2, 3-a] quinolizine ring systems, e.g. yohimbine; 16, 18-lactones thereof, e.g. reserpic acid lactone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
FR832803A 1959-09-09 1960-07-12 New drug in particular for the treatment of arterial hypertension. Expired FR31M (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR804678A FR1357608A (en) 1959-09-09 1959-09-09 Process for the preparation of a novel disubstituted derivative of deserpidine and resulting products

Publications (1)

Publication Number Publication Date
FR31M true FR31M (en) 1960-11-28

Family

ID=8718978

Family Applications (3)

Application Number Title Priority Date Filing Date
FR804678A Expired FR1357608A (en) 1959-09-09 1959-09-09 Process for the preparation of a novel disubstituted derivative of deserpidine and resulting products
FR832803A Expired FR31M (en) 1959-09-09 1960-07-12 New drug in particular for the treatment of arterial hypertension.
FR832804A Expired FR32M (en) 1959-09-09 1960-07-12 New drug 6b-ethyl deserpidic for the treatment of arterial hypertension.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR804678A Expired FR1357608A (en) 1959-09-09 1959-09-09 Process for the preparation of a novel disubstituted derivative of deserpidine and resulting products

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR832804A Expired FR32M (en) 1959-09-09 1960-07-12 New drug 6b-ethyl deserpidic for the treatment of arterial hypertension.

Country Status (1)

Country Link
FR (3) FR1357608A (en)

Also Published As

Publication number Publication date
FR1357608A (en) 1964-04-10
FR32M (en) 1960-11-28

Similar Documents

Publication Publication Date Title
FR1009M (en) Medicine for the treatment of angina pectoris.
FR31M (en) New drug in particular for the treatment of arterial hypertension.
BE605476A (en) Veterinary composition for the treatment of enterohepatitis in turkeys
FR1512M (en) New drug in particular for the treatment of arterial hypertension.
FR1466M (en) New drug in particular for the treatment of arterial hypertension.
FR151M (en) New drug, in particular for the treatment of neuro-depressive states and anxiety psychoses.
FR2576M (en) New drug, in particular for the treatment of blood coagulability disorders.
FR341M (en) New tetrahydroxylated steroid drug, in particular for the treatment of spasms of coronary origin.
FR1857M (en) New drug in particular for the treatment of diseases of viral origin.
FR3392M (en) Dermatological medicinal product, in particular for the treatment of oozing eczema.
FR363M (en) New drug for the treatment of trypanosomosis, salmonellosis and penicillofacial infections.
BE598672A (en) Therapeutic composition for the treatment of hepatic disorders.
FR2413M (en) New drug, in particular for the treatment of inflammatory and painful manifestations.
FR1122M (en) New drug in particular for the treatment of hypercholesterolemia.
FR1387M (en) New drug in particular for the treatment of acute or chronic arterial hypertension.
FR1186M (en) New drug in particular for the treatment of acute or chronic arterial hypertension.
FR1689M (en) New drug in particular for the treatment of acute or chronic arterial hypertension.
FR3096M (en) New drug in particular for the treatment of states of adynamia.
FR1830M (en) New drug in particular for the treatment of follicle-stimulating hyperactivity.
FR1780M (en) New drug in particular for the treatment of disorders of protein anabolism.
FR385M (en) New drug for the treatment of staphylococcal infections and the like.
BE630069A (en) Therapeutic composition for the treatment of parkinsonism.
FR35M (en) New drug, in particular for the treatment of hypophyseal follicle stimulating hyperactivity.
BE586332A (en) Therapeutic compositions for the treatment of hypertension
FR1172M (en) New drug especially for the treatment of ovarian irregularities and insufficiencies.